The benefit assessment of vildagliptin was conducted according to the approval for the following therapeutic indication: treatment of adult patients with type 2 diabetes mellitus.
http://ift.tt/2ssxwFN
Τετάρτη 14 Ιουνίου 2017
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Summary Insulinomas are rare neuroendocrine tumours that classically present with fasting hypoglycaemia. This case report discusses an un...
-
The online platform for Taylor & Francis Online content New for Canadian Journal of Remote Sen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου